FDA OKs Deutetrabenazine (Austedo) for Tardive Dyskinesia - Medscape

Submitted by Anonymous (not verified) on Thu, 08/31/2017 - 00:27

MedscapeFDA OKs Deutetrabenazine (Austedo) for Tardive DyskinesiaMedscapeIn reporting results of the studies at the American Psychiatric Association 2017 Annual Meeting in June, Karen E. Anderson, MD, of Georgetown University, Washington, DC, told Medscape Medical News , "In both studies, we saw significant reduction in ...and more »